EXACT Therapeutics AS (FRA:56F)

Germany flag Germany · Delayed Price · Currency is EUR
0.1170
+0.0130 (12.50%)
At close: Jan 30, 2026
-54.30%
Market Cap10.31M -41.7%
Revenue (ttm)n/a
Net Income-6.08M
EPS-0.12
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.1170
Previous Close0.1040
Day's Range0.1170 - 0.1170
52-Week Range0.0685 - 0.3040
Betan/a
RSI48.58
Earnings DateApr 9, 2026

About EXACT Therapeutics AS

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company’s ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, an... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2012
Employees 12
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 56F
Full Company Profile

Financial Performance

Financial numbers in NOK Financial Statements